Cited 0 times in
Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김성훈 | - |
dc.contributor.author | 김유나 | - |
dc.contributor.author | 박은향 | - |
dc.contributor.author | 이정윤 | - |
dc.date.accessioned | 2025-03-13T16:56:10Z | - |
dc.date.available | 2025-03-13T16:56:10Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 0020-7136 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/204225 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Wiley-Liss | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols / adverse effects | - |
dc.subject.MESH | Carcinoma, Ovarian Epithelial | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Neoplasm Recurrence, Local / drug therapy | - |
dc.subject.MESH | Ovarian Neoplasms* / drug therapy | - |
dc.subject.MESH | Ovarian Neoplasms* / genetics | - |
dc.subject.MESH | Phthalazines / adverse effects | - |
dc.title | Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics and Gynecology (산부인과학교실) | - |
dc.contributor.googleauthor | Yoo-Na Kim | - |
dc.contributor.googleauthor | Je-Gun Joung | - |
dc.contributor.googleauthor | Eunhyang Park | - |
dc.contributor.googleauthor | Jae-Weon Kim | - |
dc.contributor.googleauthor | Jung Bok Lee | - |
dc.contributor.googleauthor | Jinyeong Lim | - |
dc.contributor.googleauthor | Sunghoon Kim | - |
dc.contributor.googleauthor | Chel Hun Choi | - |
dc.contributor.googleauthor | Hee Seung Kim | - |
dc.contributor.googleauthor | Jongsuk Chung | - |
dc.contributor.googleauthor | Byoung-Gie Kim | - |
dc.contributor.googleauthor | Jung-Yun Lee | - |
dc.identifier.doi | 10.1002/ijc.34786 | - |
dc.contributor.localId | A00595 | - |
dc.contributor.localId | A05561 | - |
dc.contributor.localId | A05760 | - |
dc.contributor.localId | A04638 | - |
dc.relation.journalcode | J01092 | - |
dc.identifier.eissn | 1097-0215 | - |
dc.identifier.pmid | 37907776 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/ijc.34786 | - |
dc.contributor.alternativeName | Kim, Sung Hoon | - |
dc.contributor.affiliatedAuthor | 김성훈 | - |
dc.contributor.affiliatedAuthor | 김유나 | - |
dc.contributor.affiliatedAuthor | 박은향 | - |
dc.contributor.affiliatedAuthor | 이정윤 | - |
dc.citation.volume | 154 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 764 | - |
dc.citation.endPage | 765 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CANCER, Vol.154(4) : 764-765, 2024-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.